Core Viewpoint - Several A-share companies have reported significant profit growth forecasts for 2025, indicating a positive trend in their respective industries and potential investment opportunities [4]. Group 1: Company Performance - Jin'an Guoji (002636) expects a net profit of 280 million to 360 million yuan for 2025, representing a year-on-year increase of 655.53% to 871.4%. The growth is attributed to improved market conditions for copper-clad laminates, increased sales volume, and optimized product structure [6]. - Limin Co., Ltd. (002734) forecasts a net profit of 465 million to 500 million yuan for 2025, with a year-on-year growth of 471.55% to 514.57%. The increase is driven by higher sales volume and prices of its main products, along with improved gross margins [7]. - Juhua Co., Ltd. (600160) anticipates a net profit of 3.54 billion to 3.94 billion yuan for 2025, reflecting an 80% to 101% increase. The growth is mainly due to the recovery in prices of fluorinated refrigerants and stable production and sales [10][11]. - Shanghai Yizhong (688091) projects a net profit of 60 million to 70 million yuan for 2025, with a year-on-year increase of 760.18% to 903.54%. The growth is linked to the inclusion of its core product in the national medical insurance directory, significantly boosting market access and patient numbers [12]. Group 2: Industry Insights - The copper-clad laminate industry is experiencing a recovery in high-end market demand, driven by the growth of emerging applications in the electronics sector and government initiatives to boost consumption [6]. - The global pesticide market is expected to grow and exceed 80 billion dollars by 2025, with stable demand for pesticides as a key input for agricultural production [9].

Group 1: Company Performance Forecasts - Jin'an Guoji expects a net profit of 280 million to 360 million yuan for 2025, representing a year-on-year increase of 655.53% to 871.4% due to improved market conditions in the copper-clad laminate sector and increased sales volume and prices [3] - Limin Co. anticipates a net profit of 465 million to 500 million yuan for 2025, reflecting a year-on-year growth of 471.55% to 514.57%, driven by increased sales volume and prices, improved gross margins, and higher investment income from affiliated companies [4] - Juhua Co. forecasts a net profit of 3.54 billion to 3.94 billion yuan for 2025, with a year-on-year increase of 80% to 101%, attributed to rising prices of core products and stable production and sales volumes [6][7] - Shanghai Yizhong expects a net profit of 60 million to 70 million yuan for 2025, indicating a year-on-year growth of 760.18% to 903.54%, primarily due to the inclusion of its core product in the national medical insurance directory [8] Group 2: Industry Trends and Market Conditions - The copper-clad laminate industry is experiencing a recovery in high-end market demand, with increased investment in high-end markets and a slight rebound in prices, although competition remains fierce [3] - The global pesticide market is projected to grow and exceed 80 billion USD by 2025, driven by the need for agricultural productivity and Limin Co.'s strengthened position as a leading disinfectant manufacturer [6] - The third-generation fluorinated refrigerants are seeing price recovery and stable demand, contributing to Juhua Co.'s profit growth, while the industry is improving in terms of competition and market structure [7] - Shanghai Yizhong is focused on developing innovative anti-tumor drugs and has a comprehensive drug production system, with ongoing research into various therapeutic platforms [8]

Group 1: Profit Forecasts - Limin Co. expects a net profit of 465 million to 500 million yuan for 2025, representing a year-on-year increase of 471.55% to 514.57% [1] - Guohui Energy anticipates a net profit of 1.32 billion to 1.47 billion yuan for 2025, reflecting a decline of 50.03% to 55.13% year-on-year [2] - Jiajia Yue forecasts a net profit of 198 million to 228 million yuan for 2025, indicating a growth of 50.06% to 72.79% year-on-year [3] - Xianghe Industry projects a net profit of 120 million to 148 million yuan for 2025, with an expected increase of 59.17% to 96.31% year-on-year [4] - Aojie Technology predicts a net profit of 90 million to 120 million yuan for 2025, showing a growth of 228.34% to 337.79% year-on-year [14] - Shanghai Electric expects a net profit of 1.1 billion to 1.32 billion yuan for 2025, representing an increase of approximately 47% to 76% year-on-year [15] - Tianfu Communication anticipates a net profit of 1.881 billion to 2.15 billion yuan for 2025, reflecting a growth of 40% to 60% year-on-year [16] - Yichang Technology forecasts a net profit of 150 million to 225 million yuan for 2025, indicating a year-on-year increase of 58% to 138% [29] - Shanghai Yizhong expects a net profit of 60 million to 70 million yuan for 2025, representing a significant increase of 760.18% to 903.54% year-on-year [41] Group 2: Loss Forecasts - Kexin Electromechanical anticipates a net profit of 55 million to 70 million yuan for 2025, reflecting a decline of 58.65% to 67.51% year-on-year [11][12] - Kexin Technology expects a net loss of 900 million to 1.2 billion yuan for 2025, which is an increase in loss of 78.67% to 84% year-on-year [10] - Tianyang New Materials forecasts a net loss of 250 million to 180 million yuan for 2025, compared to a loss of 213 million yuan in the previous year [20] - Bo Rui Data anticipates a net loss of 90 million to 100 million yuan for 2025, which is an increase in loss of 15.17 million to 25.17 million yuan year-on-year [19] - Xinlian Integrated expects a net loss of 577 million yuan for 2025, which is a reduction in loss of approximately 40.02% compared to the previous year [40] - Fangshilong forecasts a net loss of 4 million to 6 million yuan for 2025 [30] Group 3: Strategic Developments - Lianlong signed a strategic framework agreement with Runyinglian to enhance the reliability and efficiency of the lubricant additive supply chain in China and the Asia-Pacific region [7] - Han Jian Heshan is planning to acquire a 52.51% stake in Liaoning Xingfu New Materials Co., Ltd., with stock suspension expected for up to 9 trading days [13] - Kai Zhong Precision plans to invest 116 million yuan in a technical transformation and expansion project to meet future capacity demands [34] - Tianfu Communication is expected to engage in clinical trials for its ABA001 injection, which has received approval from the National Medical Products Administration [17]

（记者 曾健辉） 每经AI快讯，上海谊众1月21日晚间发布业绩预告，公司预计2025年度实现归属于母公司所有者的净利 润为6000万元~7000万元；与上年同期相比，将增加5302万元~6302万元，同比增长760.18%~903.54%。 业绩变动主要原因是，公司核心产品注射用紫杉醇聚合物胶束于2025年正式纳入国家医保目录，在市场 准入与用药人数上大幅提高，带动了公司全年营收与利润相较于2024年显著增长。 每经头条（nbdtoutiao）——重磅数据公布：回升！专访徐洪才："内卷式竞争"得到一定缓解，下一 步"补收入"可形成良性循环 ...

新京报贝壳财经讯 1月21日，上海谊众公告，预计2025年度实现归属于母公司所有者的净利润为6000万 元到7000万元，与上年同期相比，增长760.18%到903.54%。公司核心产品注射用紫杉醇聚合物胶束于 2025年正式纳入国家医保目录，在市场准入与用药人数上大幅提高，带动了公司全年营收与利润相较于 2024年显著增长。 ...

上海谊众(688091.SH)发布2025年年度业绩预告公告，预计2025年度实现归属于母公司所有者的净利润 为6,000万元到7,000万元;与上年同期相比，增长760.18%到903.54%。 本期业绩变化的主要原因：公司核心产品注射用紫杉醇聚合物胶束(以下简称"紫杉醇胶束")于2025年正 式纳入国家医保目录，在市场准入与用药人数上大幅提高，带动了公司全年营收与利润相较于2024年显 著增长。 ...

人民财讯1月21日电，上海谊众(688091)1月21日公告，预计2025年度实现归属于母公司所有者的净利润 为6000万元到7000万元，同比增长760.18%到903.54%。公司核心产品注射用紫杉醇聚合物胶束(简称"紫 杉醇胶束")于2025年正式纳入国家医保目录，在市场准入与用药人数上大幅提高，带动了公司全年营收 与利润相较于2024年显著增长。 ...

本期业绩变化的主要原因：公司核心产品注射用紫杉醇聚合物胶束(以下简称"紫杉醇胶束")于2025年正 式纳入国家医保目录，在市场准入与用药人数上大幅提高，带动了公司全年营收与利润相较于2024年显 著增长。 智通财经APP讯，上海谊众(688091.SH)发布2025年年度业绩预告公告，预计2025年度实现归属于母公 司所有者的净利润为6,000万元到7,000万元;与上年同期相比，增长760.18%到903.54%。 ...

格隆汇1月21日丨上海谊众(688091.SH)公布，公司预计2025年度实现归属于母公司所有者的净利润为 6000万元到7000万元；与上年同期相比，增长760.18%到903.54%。 公司预计2025年归属于母公司所有者的扣除非经常性损益的净利润为5600万元到6600万元；与上年同期 相比，增长1338.87%到1595.81%。 ...

证券代码：688091 证券简称：上海谊众 公告编号：2026-001 上海谊众药业股份有限公司 2025 年年度业绩预告公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 一、 本期业绩预告情况 （一）业绩预告时间 2025 年 1 月 1 日—2025 年 12 月 31 日 （二）业绩预告情况 1、经财务部门初步测算，公司预计 2025 年度实现归属于母公司所有者的净利润为 6,000 万元到 7,000 万元；与上年同期相比，将增加 5,302 万元到 6,302 万元，同比增长 760.18%到 903.54%。 2、公司预计 2025 年归属于母公司所有者的扣除非经常性损益的净利润为 5,600 万 元到 6,600 万元；与上年同期相比，将增加 5,211 万元到 6,211 万元，同比增长 1,338.87% 到 1,595.81%。 （三） 本次业绩预告未经注册会计师审计。 三、 本期业绩变化的主要原因 公司核心产品注射用紫杉醇聚合物胶束（以下简称"紫杉醇胶束"）于 2025 年正式 纳 ...